To gain more insights into the tumorigenic capacity of CD90+ stem cells in liver cancer, the correlation of major SHH/Gli signalling components such as Gli1 and Gli3 with CD90 expression in multiple liver cancer cell lines and tissue samples was evaluated in this study. This evidence concerns the gene GLI3 and liver cancer.